Agenus Inc.
AGEN
$1.86
$0.18511.05%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
MarketBeat
3/13/2025
-
MarketBeat
3/13/2025
-
TipRanks Financial Blog
3/12/2025
-
MarketBeat
3/12/2025
-
The Fly
3/12/2025
-
GuruFocus
3/12/2025
-
GuruFocus
3/12/2025
-
TipRanks Financial Blog
3/11/2025
-
Fool.com Headlines
3/11/2025
-
Seeking Alpha - Healthcare
3/11/2025
-
Seeking Alpha: Transcripts
3/11/2025
-
SeekingAlpha
3/11/2025
-
Zacks Investment Research
3/11/2025
-
GuruFocus
3/11/2025
-
The Fly
3/11/2025
-
Business Wire
3/10/2025
-
SeekingAlpha.com: All News
3/1/2025
-
MarketBeat
2/26/2025
-
Business Wire
2/25/2025
-
GuruFocus
2/25/2025
-
Business Wire
2/25/2025
-
GuruFocus
2/25/2025
-
Business Wire
2/24/2025
-
GuruFocus
2/24/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 674 4400
Address
3 Forbes Road
Lexington, MA 02421-7305
Lexington, MA 02421-7305
Country
Year Founded
Business Description
Sector
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody...
more
